An Introduction to Movement Disorders
Movement disorders encompass a range of conditions including ataxia, dystonia, essential tremor, multiple system atrophy, Parkinson’s disease (PD) and restless legs syndrome. The treatment landscape of PD has seen numerous developments, including the introduction of dopamine agonists and MAO-B inhibitors, along with device-assisted therapies that prove particularly useful in advanced-stage disease. The first-line treatment of ataxia with botulinum toxin is long established, but new preparations of the drug are likely to contribute to the future landscape.
Browse video highlights and short articles from the conference hub, providing insights into the latest updates from major conferences and peer-reviewed articles from the journal portfolio. This is complimented by a range of educational activities from our expert faculty, with patient outcomes at the forefront.
Movement Disorders Content
EAN 2020 – Time for Action. Predict. Prevent. Repair.
EAN President, Prof. Claudio Bassetti invites you to participate in the EAN 2020 congress. You can register for the virtual congress free-of-charge here. It’s a fantastic opportunity for everyone in the neurology community to benefit from the possibility of education, scientific news and best practice exchange from the comfort of home. Be sure to visit our EAN […]
Foreword – US Neurology. 2019;15(1):9
US Neurology. 2019;15(1):9
Welcome to the spring edition of US Neurology. This journal aims to address topical subjects in the field of neurology to stimulate discussion focused on these issues. Articles have been chosen for their evaluation of current practices and research and their discussion of future innovations that directly affect neurologists and other practitioners involved in the care […]
Angela Vincent, MDS 2019 – Autoimmune movement disorders
It was an absolute pleasure to meet with Angela Vincent, Emeritus Professor of Neuroimmunology at the University of Oxford. Until 2016 she led the clinical and research laboratory at Oxford specialising in antibody-mediated neurological diseases. Despite not being a neurologist herself, she spoke from long experience of helping to identify and characterise pathogenic antibodies in […]
Hélio AG Teive, MDS 2019 – Spinocerebellar ataxia
MDS Congress Scientific Program Committee member, Hélio AG Teive (Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil) kindly talked to us about spinocerebellar ataxia and its geographical diversity. Questions 1. How does spinocerebellar ataxia differ from other ataxias? (0:05) 2. In what regions is spinocerebellar ataxia found? (0:26) 3. What is the reason for […]
touchNEUROLOGY highlights from MDS 2019 – Day 2
Highlights from day 2 of the touchNEUROLOGY expert interviews filmed at MDS 2019 in Nice, France, 23 September 2019.
touchNEUROLOGY Highlights from MDS 2019 – Day 1
Highlights from day 1 of the touchNEUROLOGY expert interviews filmed at MDS 2019 in Nice, France, 23 September 2019.
Marianne de Visser, EAN 2019 – Neurology and palliative care
EAN Secretary General and one of the newest additions to our European editorial board, Marianne de Visser (Amsterdam University Medical Centre, Netherlands) discusses the overarching theme of several of her presentations at EAN 2019 – neurology and palliative care. Questions 1. What are the major unmet needs in palliative care for people with neurological diseases? […]
touchNEUROLOGY Highlights from EAN 2019 – Day 2
Highlights from day 2 of the touchNEUROLOGY expert interviews filmed at EAN 2019 in Oslo, Norway, 1 July 2019.
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!